Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Arvinas, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 223
- +12 vs. Q4 2023
- Shares held
- 68.8M
- +4.03M (+6.2%) vs. Q4 2023
- Total value
- $2.84B
- +$173.4M (+6.5%) vs. Q4 2023
- New holders
- 38
- 84 more added
- Sold out
- 26
- 67 more reduced
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| VR Adviser, LLC | 627,788 | $25.9M | 1.23% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 630,000 | $26.0M | 0.05% | −159,485−20.2% | Reduced |
| Morgan Stanley | 675,509 | $27.9M | 0.00% | −17,970−2.6% | Reduced |
| Norges Bank | 1,108,768 | $45.8M | 0.01% | +231,060+26.3% | Added |
| ArrowMark Colorado Holdings LLC | 1,205,568 | $49.8M | 0.57% | −364,327−23.2% | Reduced |
| Perceptive Advisors LLC | 1,236,603 | $51.0M | 0.90% | +882,521+249.2% | Added |
| Commodore Capital LP | 1,275,000 | $52.6M | 3.52% | +275,000+27.5% | Added |
| New Leaf Venture Partners, L.L.C. | 1,289,521 | $53.2M | 46.59% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,313,316 | $54.2M | 0.01% | +190,689+17.0% | Added |
| State Street Corp | 1,382,167 | $57.1M | 0.00% | +195,693+16.5% | Added |
| Nextech Invest AG | 1,408,394 | $58.1M | 9.22% | −287,251−16.9% | Reduced |
| JPMorgan Chase & Co | 1,699,843 | $70.2M | 0.01% | −472,986−21.8% | Reduced |
| Citadel Advisors LLC | 2,280,613 | $94.1M | 0.09% | −159,368−6.5% | Reduced |
| FMR LLC | 2,388,954 | $98.6M | 0.01% | +144,935+6.5% | Added |
| Bellevue Group AG | 2,390,800 | $98.7M | 1.51% | −116,931−4.7% | Reduced |
| Paradigm Biocapital Advisors LP | 2,614,935 | $107.9M | 3.80% | +1,683,632+180.8% | Added |
| Avidity Partners Management LP | 2,985,190 | $123.2M | 4.38% | +730.0% | Added |
| RTW Investments, LP | 3,297,897 | $136.1M | 2.01% | −915,586−21.7% | Reduced |
| Price T Rowe Associates Inc | 4,368,418 | $180.3M | 0.02% | +536,295+14.0% | Added |
| BlackRock Inc. | 5,494,254 | $226.8M | 0.01% | +139,390+2.6% | Added |
| Vanguard Group Inc | 6,299,556 | $260.0M | 0.01% | +1,448,166+29.9% | Added |
| EcoR1 Capital, LLC | 6,726,491 | $277.7M | 7.06% | 00.0% | Unchanged |
| Portland Investment Counsel Inc. | 5,000 | – | – | +5,000 | New |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −744,465−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −66,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −58,790−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −47,066−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −31,210−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −28,070−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −21,607−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,273−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −17,028−100.0% | Sold out |
| Rossmore Private Capital | 0 | $0 | 0.00% | −14,322−100.0% | Sold out |
| Joel Isaacson & Co., LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Concurrent Investment Advisors, LLC | 0 | $0 | 0.00% | −8,771−100.0% | Sold out |
| Petrus Trust Company, LTA | 0 | $0 | 0.00% | −6,823−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −6,727−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −6,465−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −6,474−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −6,419−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −2,388−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −2,216−100.0% | Sold out |
| McGlone Suttner Wealth Management, Inc. | 0 | $0 | 0.00% | −1,821−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | – | Sold out |
| Raleigh Capital Management Inc. | 0 | $0 | 0.00% | −589−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −435−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |